Atea ASA
136.80
22-January-25 10:19:40
15 minutes delayed
Stocks
+1.00
+0.74%
Today's range
136.20 - 137.50
ISIN
NO0004822503
Source
Cboe
-
Evolent Health (NYSE:EVH) Reaches New 1-Year Low on Analyst Downgrade
22 Jan 2025 11:51:17 By Buzz FX
-
Hancock Whitney (NASDAQ:HWC) Given "Overweight" Rating at Stephens
22 Jan 2025 11:51:17 By Buzz FX
-
Nexstar Media Group (NASDAQ:NXST) Earns "Buy" Rating from Guggenheim
22 Jan 2025 11:51:17 By Buzz FX
-
Ultragenyx Pharmaceutical's (RARE) "Overweight" Rating Reiterated at Cantor Fitzgerald
22 Jan 2025 11:51:17 By Buzz FX
-
Sanara MedTech's (SMTI) Overweight Rating Reaffirmed at Cantor Fitzgerald
22 Jan 2025 11:51:17 By Buzz FX
-
Piper Sandler Has Lowered Expectations for Pathward Financial (NASDAQ:CASH) Stock Price
22 Jan 2025 11:51:17 By Buzz FX
-
Stephens Lowers Eagle Materials (NYSE:EXP) Price Target to $310.00
22 Jan 2025 11:51:17 By Buzz FX
-
HUL reports flat volume growth amid shift to smaller packs in urban markets
22 Jan 2025 11:45:29 By Buzz FX
-
USD: Trump Tariff Threat On Russia Adds To USD Bid
22 Jan 2025 11:36:28 By Buzz FX
-
Trade War Threatens Canadian Banks Stocks' Rally After 27% Surge
22 Jan 2025 11:31:16 By Buzz FX
-
STIR: A Little Over 65bp Of BoE Cuts Priced For '25, Despite Uptick In Yields
22 Jan 2025 11:30:30 By Buzz FX
-
Meta Platforms (NASDAQ:META) Stock Price Up 1.8% on Analyst Upgrade
22 Jan 2025 11:27:17 By Buzz FX
-
GE Vernova (NYSE:GEV) Trading 1.6% Higher on Analyst Upgrade
22 Jan 2025 11:27:17 By Buzz FX
-
Rivian Automotive (NASDAQ:RIVN) Price Target Raised to $14.00 at Barclays
22 Jan 2025 11:27:17 By Buzz FX
-
Barclays Lowers American Axle & Manufacturing (NYSE:AXL) Price Target to $7.00
22 Jan 2025 11:27:17 By Buzz FX
-
First Solar (NASDAQ:FSLR) Given "Buy" Rating at Guggenheim
22 Jan 2025 11:27:17 By Buzz FX
-
Dynatrace's (DT) "Neutral" Rating Reaffirmed at Guggenheim
22 Jan 2025 11:27:17 By Buzz FX
-
8 Best Cyclical Stocks to Buy According to Hedge Funds
22 Jan 2025 11:26:28 By Buzz FX
-
Marvell Technology (NASDAQ:MRVL) Stock Price Up 0.8% After Analyst Upgrade
22 Jan 2025 11:26:18 By Buzz FX
-
Guggenheim Reaffirms "Buy" Rating for Century Therapeutics (NASDAQ:IPSC)
22 Jan 2025 11:26:18 By Buzz FX